Skip to content Skip to footer
Vismodegib: Benefits, Reviews, Info, Side Effects!
Rx Details
Vismodegib
Erivedge, GDC-0449
Vismodegib
Prescription
Drug
Drugs
Prescription Only
treatment of basal cell carcinoma
Altered Taste, Constipation, Decreased Appetite, Diarrhea, Dry Skin, Fatigue, Hair Loss, Headache, Itching, Joint Pain, Loss Of Menstrual Periods, Muscle Spasms, Nausea, Vomiting, Weight Loss
Vismodegib is a medication used primarily for the treatment of basal cell carcinoma. The typical dosage for vismodegib is 150 mg taken orally once daily. However, it’s important to follow the specific instructions provided by a healthcare professional, as they may adjust the dosage based on individual patient needs and response to treatment. Always consult with a healthcare provider for personalized medical advice.
Basal cell carcinoma
Vismodegib has a moderate safety profile.
No Interactions Reported
$1,500 – $2,000
$10,000

A Synopsis of

Vismodegib

Vismodegib is a medication that is commonly used in the treatment of basal cell carcinoma, a type of skin cancer. It works by inhibiting a specific protein in the body that is responsible for the growth and spread of cancer cells. This drug is typically prescribed for patients who have advanced basal cell carcinoma that cannot be treated with surgery or radiation therapy.

It is important to follow your healthcare provider’s instructions carefully when taking Vismodegib. This medication is usually taken orally once a day, with or without food. It is important to take the medication at the same time each day to maintain a consistent level of the drug in your system.

Like all medications, Vismodegib can cause side effects. Some common side effects of this drug include muscle spasms, hair loss, weight loss, and fatigue. It is important to report any side effects to your healthcare provider so they can monitor your condition and make any necessary adjustments to your treatment plan.

It is also important to inform your healthcare provider of any other medications or supplements you are taking, as they may interact with Vismodegib. Additionally, women who are pregnant or breastfeeding should not take this medication, as it can cause harm to the developing fetus or nursing infant.

Overall, Vismodegib is an important medication in the treatment of basal cell carcinoma. By following your healthcare provider’s instructions and reporting any side effects, you can help ensure the effectiveness and safety of this medication in your treatment plan.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN